The Office of New Animal Drug Evaluation (ONADE) at FDA’s Center for Veterinary Medicine held a public meeting entitled “Antiparasitic Drug Use and Resistance in Ruminants and Equines” on March 5 and 6, 2012.
The public meeting targeted industry and academic stakeholders interested in antiparasitic resistance in the United States. Meeting attendees explored and discussed ways antiparasitic drugs can be used, alone or in combination, to maximize drug effectiveness and minimize resistance in ruminants and equines.
Seven internationally recognized veterinary parasitology experts gave PowerPoint presentations on a range of topics related to antiparasitic resistance in the United States. FDA also invited the public to speak during the meeting’s two open comment periods. A transcript of the two-day meeting is available on FDA’s website.
After the meeting, there was a 60-day open comment period for the public to submit comments to the docket. These comments are also available on FDA’s website.
To navigate the meeting documents:
- Click on the link for the docket.
- Click on the link in the docket labeled “testimony” for the presentations.
- Click on the link in the docket labeled “transcript” for the transcript of the two-day meeting.
- Click on the remaining links to view submitted public comments.
For questions or feedback about the public meeting, please contact the following ONADE staff:
- Dr. Michelle Kornele at 240-276-8355 or email@example.com (ruminants)
- Dr. Anna O’Brien at 240-276-8343 or firstname.lastname@example.org (ruminants)
- Dr. Aimee Phillippi-Taylor at 240-276-8335 or email@example.com (equines)
Public Meeting Links
- Docket for Antiparasitic Drug Use and Resistance in Ruminants and Equines Public Meeting
Final Agenda - Antiparasitic Drug Use and Resistance in Ruminants and Equines Public Meeting, 3/5/2012 and 3/6/2012[ARCHIVED]
- Federal Register Notice of a Public Meeting on Antiparasitic Drug Use and Resistance in Ruminants and Equines